Search
[email protected]

DxTerity Diagnostics Announces the Launch of IFN-1 Test for Lupus

Jun 09, 2022 DxTerity Diagnostics today announced the commercial launch of their IFN-1 Test for patients with Systemic Lupus Erythematosus (SLE or lupus). The IFN-1 Test supports the advancement of precision medicine to improve the lives of patients living with lupus. DxTerity’s test measures a key biomarker, Type-1 Interferon (IFN-1), an important indicator of SLE […]

A Digital Assay to Streamline PD-L1 IHC: Published in Scientific Reports

Jun 14, 2022 Flagship Biosciences, Inc., today announced the publication of a paper describing validation of a novel digital spatial biology assay in Scientific Reports. The assay, Tissue Insight (TI) 22C3 NSCLC, surpasses manual scoring in PD-L1 positive tumor samples. Modern cancer immunotherapy for non-small cell lung cancer (NSCLC) utilizes programmed death-ligand 1 (PD-L1) checkpoint […]